XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized (Losses) Gains on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2022 $ 81,450 $ 9 $ 0 $ 86,156 $ (2,778) $ (5,615) $ 3,678
Balance (in shares) at Dec. 31, 2022   934          
Net earnings attributable to UnitedHealth Group common shareholders 11,085     11,085      
Net earnings attributable to nonredeemable noncontrolling interest             252
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 11,337            
Other comprehensive income (loss) 743       135 608  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 568 $ 0 568        
Share-based compensation 598   598        
Common share repurchases (in shares)   (10)          
Common share repurchases (5,038) $ 0 (1,075) (3,963)      
Cash dividends paid on common shares (3,284)     (3,284)      
Redeemable noncontrolling interests fair value and other adjustments (91)   (91)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 1,297           1,297
Distribution to nonredeemable noncontrolling interests (212)           (212)
Balance at Jun. 30, 2023 $ 87,368 $ 9 0 89,994 (2,643) (5,007) 5,015
Balance (in shares) at Jun. 30, 2023   927          
Common Stock, Dividends, Per Share, Cash Paid $ 3.53            
Balance at Mar. 31, 2023 $ 85,821 $ 9 0 88,852 (2,275) (5,274) 4,509
Balance (in shares) at Mar. 31, 2023   932          
Net earnings attributable to UnitedHealth Group common shareholders 5,474     5,474      
Net earnings attributable to nonredeemable noncontrolling interest             139
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,613            
Other comprehensive income (loss) (101)       (368) 267  
Issuances of common stock, and related tax effects (in shares)   1          
Issuances of common stock, and related tax effects 218 $ 0 218        
Share-based compensation 232   232        
Common share repurchases (in shares)   (6)          
Common share repurchases (3,027) $ 0 (442) (2,585)      
Cash dividends paid on common shares (1,747)     (1,747)      
Redeemable noncontrolling interests fair value and other adjustments (8)   (8)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 478           478
Distribution to nonredeemable noncontrolling interests (111)           (111)
Balance at Jun. 30, 2023 $ 87,368 $ 9 0 89,994 (2,643) (5,007) 5,015
Balance (in shares) at Jun. 30, 2023   927          
Common Stock, Dividends, Per Share, Cash Paid $ 1.88            
Balance at Dec. 31, 2023 $ 94,421 $ 9 0 95,774 (1,971) (5,056) 5,665
Balance (in shares) at Dec. 31, 2023 924 924          
Net earnings attributable to UnitedHealth Group common shareholders $ 2,807     2,807      
Net earnings attributable to nonredeemable noncontrolling interest             307
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 3,114            
Other comprehensive income (loss) 3,604       (325) 3,929  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 438 $ 0 438        
Share-based compensation 562   562        
Common share repurchases (in shares)   (6)          
Common share repurchases (3,088) $ 0 (571) (2,517)      
Cash dividends paid on common shares (3,664)     (3,664)      
Redeemable noncontrolling interests fair value and other adjustments (56)   (56)        
Acquisition and other adjustments of nonredeemable noncontrolling interests (319)           (319)
Distribution to nonredeemable noncontrolling interests (336)           (336)
Balance at Jun. 30, 2024 $ 94,676 $ 9 373 92,400 (2,296) (1,127) 5,317
Balance (in shares) at Jun. 30, 2024 921 921          
Common Stock, Dividends, Per Share, Cash Paid $ 3.98            
Balance at Mar. 31, 2024 $ 92,370 $ 9 0 90,118 (2,218) (1,221) 5,682
Balance (in shares) at Mar. 31, 2024   920          
Net earnings attributable to UnitedHealth Group common shareholders 4,216     4,216      
Net earnings attributable to nonredeemable noncontrolling interest             158
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 4,374            
Other comprehensive income (loss) 16       (78) 94  
Issuances of common stock, and related tax effects (in shares)   1          
Issuances of common stock, and related tax effects 196 $ 0 196        
Share-based compensation 210   210        
Common share repurchases (in shares)   0          
Common share repurchases 4 $ 0 3 1      
Cash dividends paid on common shares (1,935)     (1,935)      
Redeemable noncontrolling interests fair value and other adjustments (36)   (36)        
Acquisition and other adjustments of nonredeemable noncontrolling interests (338)           (338)
Distribution to nonredeemable noncontrolling interests (185)           (185)
Balance at Jun. 30, 2024 $ 94,676 $ 9 $ 373 $ 92,400 $ (2,296) $ (1,127) $ 5,317
Balance (in shares) at Jun. 30, 2024 921 921          
Common Stock, Dividends, Per Share, Cash Paid $ 2.10